AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Sep 5, 2012
30016_dirs_2012-09-05_e5411d22-ceba-4318-a13d-68cd3e8c6548.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-01
Reporting Person: SZOSTAK M ANNE (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-01 | Non-Qualified Stock Option (right to buy) | $95.06 | A | 2953 | Acquired | 2019-08-31 | Common Stock (2953) | Direct |
| 2012-09-01 | Deferred Stock Unit | $ | A | 284 | Acquired | Common Stock (284) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock that vest 100% on 05/09/2013.
F2: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% on 05/09/2013 and are payable as common stock one year following the Director's resignation from the Board of Directors.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13